Leap Therapeutics Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
- Sysco calls on Teamsters to end LA strike after economic deal reached
Leap Therapeutics, Inc. (LPTX) Misses Q2 EPS by 5c
August 12, 2022 7:05 AM EDTLeap Therapeutics, Inc. (NASDAQ: LPTX) reported Q2 EPS of ($0.15), $0.05 worse than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Leap Therapeutics, Inc. (LPTX) click here.
... More


